UnitedHealth Group Incorporated (UNH) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
UNH Revenue Growth
Revenue Breakdown (FY 2025)
UNH's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
UNH Revenue Analysis (2014–2025)
As of May 6, 2026, UnitedHealth Group Incorporated (UNH) generated trailing twelve-month (TTM) revenue of $449.71 billion, reflecting modest growth of +2.0% year-over-year. The most recent quarter (Q1 2026) recorded $111.72 billion in revenue, down 1.3% sequentially.
Looking at the longer-term picture, UNH's 5-year compound annual growth rate (CAGR) stands at +11.7%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $447.57 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows UNH's business is primarily driven by Unitedhealthcare (94%), and Optumhealth (6%). With over half of revenue concentrated in Unitedhealthcare, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including CVS (+7.8% YoY), ELV (+9.4% YoY), and CI (+8.8% YoY), UNH has underperformed the peer group in terms of revenue growth. Compare UNH vs CVS →
UNH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| UNHCurrent | $449.7B | +2.0% | +11.7% | 4.2% | |
 CVS | $402.1B | +7.8% | +8.4% | 2.6% | |
 ELV | $199.1B | +9.4% | +10.3% | 4.1% | |
 CI | $275.0B | +8.8% | +11.4% | 3.3% | |
 HUM | $129.7B | +14.1% | +10.9% | 1.1% | |
 CNC | $194.8B | +17.0% | +11.9% | -3.9% |
UNH Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $447.57B | +11.8% | $82.92B | 18.5% | $18.96B | 4.2% |
| 2024 | $400.28B | +7.7% | $89.40B | 22.3% | $32.29B | 8.1% |
| 2023 | $371.62B | +14.6% | $90.96B | 24.5% | $32.36B | 8.7% |
| 2022 | $324.16B | +12.7% | $79.62B | 24.6% | $28.43B | 8.8% |
| 2021 | $287.60B | +11.8% | $69.65B | 24.2% | $23.97B | 8.3% |
| 2020 | $257.14B | +6.2% | $67.00B | 26.1% | $22.41B | 8.7% |
| 2019 | $242.16B | +7.0% | $57.60B | 23.8% | $19.68B | 8.1% |
| 2018 | $226.25B | +12.5% | $53.85B | 23.8% | $17.34B | 7.7% |
| 2017 | $201.16B | +8.8% | $47.01B | 23.4% | $15.21B | 7.6% |
| 2016 | $184.84B | +17.7% | $43.39B | 23.5% | $12.93B | 7.0% |
Full UNH Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy UNH Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See UNH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs UNH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare UNH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonUNH — Frequently Asked Questions
Quick answers to the most common questions about buying UNH stock.
Is UNH's revenue growth accelerating or slowing?
UNH revenue growth slowed to +2.0%, below the 5-year CAGR of +11.7%. TTM revenue is $449.7B. The deceleration marks a shift from historical growth rates.
What is UNH's long-term revenue growth rate?
UnitedHealth Group Incorporated's 5-year revenue CAGR of +11.7% reflects the variable expansion pattern. Current YoY growth of +2.0% is near this long-term average.
How is UNH's revenue distributed by segment?
UNH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.